Mon, July 25, 2022

Ryan Tomasello Downgraded (BLND) to Sell and Decreased Target to $2.75 on, Jul 25th, 2022

Ryan Tomasello of Keefe, Bruyette & Woods, Downgraded "Blend Labs, Inc." (BLND) to Sell and Decreased Target from $4 to $2.75 on, Jul 25th, 2022.

Ryan has made no other calls on BLND in the last 4 months.



There are 8 other peers that have a rating on BLND. Out of the 8 peers that are also analyzing BLND, 7 agree with Ryan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Arvind Ramnani of "Piper Sandler" Maintained at Hold with Decreased Target to $2.5 on, Monday, July 18th, 2022
  • Josh Beck of "Keybanc" Downgraded from Buy to Hold and Held Target at $5 on, Thursday, July 7th, 2022
  • Jason Weaver of "Compass Point" Initiated at Hold and Held Target at $4.2 on, Wednesday, May 25th, 2022
  • Michael Turrin of "Wells Fargo" Maintained at Hold with Decreased Target to $3 on, Friday, May 13th, 2022
  • Bhavan Suri of "William Blair" Downgraded from Buy to Hold on, Monday, April 4th, 2022
  • Joseph Vafi of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $5 on, Friday, April 1st, 2022
  • Terry Tillman of "Truist Securities" Maintained at Hold with Decreased Target to $5.5 on, Friday, April 1st, 2022


This is the rating of the analyst that currently disagrees with Ryan


  • Michael Ng of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $7 on, Tuesday, April 19th, 2022